THOP1 gene suppression strongly affected the clinical performance of mice in experimental EAE: an animal model of multiple sclerosis, a chronic neuroinflammatory demyelinating disorder of the CNS with a marked neurodegenerative component initiated by CD4+ T cells [74,75]. The gene discussed is CD4; the disease is multiple sclerosis.